Om
Hans Ivar Robinson has 30 years professional experience in the pharmaceutical and biotech…
Aktivitet
-
Heading to the 2024 ASCO Annual meeting in Chicago - May 31st - June 4th? You can catch Dr David Krige, Accession's Head of Translational…
Heading to the 2024 ASCO Annual meeting in Chicago - May 31st - June 4th? You can catch Dr David Krige, Accession's Head of Translational…
Likt av Hans Ivar Robinson
-
Join me at #BIO2024 in San Diego to hear about Accession Therapeutics' TROCEPT platform creating the ideal immunotherapy and our plans of entering…
Join me at #BIO2024 in San Diego to hear about Accession Therapeutics' TROCEPT platform creating the ideal immunotherapy and our plans of entering…
Likt av Hans Ivar Robinson
-
🆕 Our new £25m financing means the #TROCEPT platform for creating ideal immunotherapies has attracted over £50m to Accession Therapeutics…
🆕 Our new £25m financing means the #TROCEPT platform for creating ideal immunotherapies has attracted over £50m to Accession Therapeutics…
Likt av Hans Ivar Robinson
Erfaring og utdanning
-
Nextera AS
Vis hele erfaringen til Hans Ivar
Se tittel, ansettelsestid med mer.
eller
Flere aktiviteter etter Hans Ivar
-
Zelluna Immunotherapy to present at the 9th Annual Innate Killer Summit 2024. We are delighted to have two presentations at the #innatekiller2024…
Zelluna Immunotherapy to present at the 9th Annual Innate Killer Summit 2024. We are delighted to have two presentations at the #innatekiller2024…
Likt av Hans Ivar Robinson
-
What’s the excitement about TCR-NKs? Our CEO, Namir Hassan explains at the #cartcr2024 Summit Europe. Whilst T Cell Receptor (TCR) based therapies…
What’s the excitement about TCR-NKs? Our CEO, Namir Hassan explains at the #cartcr2024 Summit Europe. Whilst T Cell Receptor (TCR) based therapies…
Likt av Hans Ivar Robinson
-
Dr Bent Jakobsen appointed as Executive Chairman of the Board having served on the Board since 2019. Dr Jakobsen has been an instrumental member of…
Dr Bent Jakobsen appointed as Executive Chairman of the Board having served on the Board since 2019. Dr Jakobsen has been an instrumental member of…
Likt av Hans Ivar Robinson
-
Last up on our November conference schedule is the 15th Annual PEGS Europe Conference in Lisbon, 14-16th November. Bent Jakobsen, Accession's CEO…
Last up on our November conference schedule is the 15th Annual PEGS Europe Conference in Lisbon, 14-16th November. Bent Jakobsen, Accession's CEO…
Likt av Hans Ivar Robinson
-
When done the right way, #ai (augmented intelligence) can deepen our insights and support more efficient and better treatment decisions in medicine…
When done the right way, #ai (augmented intelligence) can deepen our insights and support more efficient and better treatment decisions in medicine…
Likt av Hans Ivar Robinson
-
💪 "Det er forsvinnende få som med vilje velger bort et aktivt liv i arbeid til fordel for et passivt liv i utenforskap. En av framtidens største…
💪 "Det er forsvinnende få som med vilje velger bort et aktivt liv i arbeid til fordel for et passivt liv i utenforskap. En av framtidens største…
Likt av Hans Ivar Robinson
-
ARTBIO on a roll. Congrats to Emanuele Ostuni and team, BoD and owners. Proud and humble to be part of this journey. More to come! #alpha…
ARTBIO on a roll. Congrats to Emanuele Ostuni and team, BoD and owners. Proud and humble to be part of this journey. More to come! #alpha…
Likt av Hans Ivar Robinson
-
I am happy to share our latest work and important milestone in my PhD project. In this study we have found that a medication optimization…
I am happy to share our latest work and important milestone in my PhD project. In this study we have found that a medication optimization…
Likt av Hans Ivar Robinson
-
We had an incredible time at PEGS Europe! 🌟 The past few days in Lisbon were filled with fantastic presentations, engaging discussions, and the…
We had an incredible time at PEGS Europe! 🌟 The past few days in Lisbon were filled with fantastic presentations, engaging discussions, and the…
Likt av Hans Ivar Robinson
-
We are #hiring! As we continue to embark on our #pioneering journey, developing novel T Cell Receptor guided Natural Killer cells (TCR-NK) for the…
We are #hiring! As we continue to embark on our #pioneering journey, developing novel T Cell Receptor guided Natural Killer cells (TCR-NK) for the…
Likt av Hans Ivar Robinson
-
You can meet our Chief Operating Officer, Andrew 'Jez' Gerry & Hardev Pandha, our Medical Director, at the 15th Annual International Oncolytic…
You can meet our Chief Operating Officer, Andrew 'Jez' Gerry & Hardev Pandha, our Medical Director, at the 15th Annual International Oncolytic…
Likt av Hans Ivar Robinson
-
Wonderful to have the opportunity to present the compelling pre-clinical data on our TROCEPT platform at #sitc2023 in San Diego on behalf of my…
Wonderful to have the opportunity to present the compelling pre-clinical data on our TROCEPT platform at #sitc2023 in San Diego on behalf of my…
Likt av Hans Ivar Robinson
-
Farewell #sitc2023! The #zelluna team Justyna Kmiecik, PhD Sylvie Pollmann Kenneth LaMontagne, PhD, MBA Luise Weigand Anders Holm and Namir Hassan…
Farewell #sitc2023! The #zelluna team Justyna Kmiecik, PhD Sylvie Pollmann Kenneth LaMontagne, PhD, MBA Luise Weigand Anders Holm and Namir Hassan…
Likt av Hans Ivar Robinson